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 ❚ ABSTRACT
Objective: To compare the use of the radiofrequency thermoablation of the saphenous vein with 
the ligation technique, and complete removal of the saphenous vein, from the saphenofemoral 
junction to the ankle. Methods: A total of 49 patients with chronic venous disease in the 
Comprehensive Classification System for Chronic Venous Disorders (CEAP) classes 2 to 4 for 
clinical signs, etiology, anatomic distribution and pathophysiology, were assessed at baseline, 
after 4 weeks, and after 1 year. The parameters assessed were complications, period of absence 
from activities, Venous Clinical Severity Score (VCSS) and quality of life scores according to 
Aberdeen Varicose Veins Questionnaire (AVVQ). They were re-examined 1 and 3 years after 
treatment to evaluate recurrence rates. Results: The success rate per limb (p=0.540), VCSS 
(p=0.636), AVVQ (p=0.163), and clinical complications were similar in the two treatment 
groups. Nevertheless, the radiofrequency thermoablation group had significant shorter length 
of hospital stay (0.69±0.47) and absence from activities (8.62±4.53), p<000.1. Conclusion: 
Patients submitted to radiofrequency thermoablation had an occlusion rate, clinical recurrence 
and improvement in quality of life comparable to removal of the saphenous vein. However, these 
patients spent less time hospitalized and away from their daily activities during recovering.
Keywords: Catheter ablation/methods; Saphenous vein/surgery; Radio waves; Quality of life
 ❚ RESUMO
Objetivo: Comparar o uso da termoablação por radiofrequência da veia safena com a técnica 
de ligação e retirada completa da veia safena da junção safeno-femoral ao tornozelo. Métodos: 
Foram avaliados 49 pacientes com doença venosa crônica nas categorias 2 a 4 (Comprehensive 
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Classification System for Chronic Venous Disorders − CEAP) 
para classificação clínica, etiológica, anatômica e fisiopatológica, 
no início do estudo, 4 semanas e 1 ano após o procedimento. Os 
parâmetros analisados foram complicações, período de ausência 
de atividades, Venous Clinical Severity Score revisado (R-VCSS) e 
escore de qualidade de vida de acordo com o Aberdeen Varicose 
Veins Questionnaire (AVVQ). Os pacientes foram reexaminados 1 
e 3 anos após o tratamento, para avaliar as taxas de recorrência. 
Resultados: As taxas de sucesso por membro (p=0,540), VCSS 
(p=0,636), AVVQ (p=0,163) e complicações clínicas foram 
semelhantes nos dois grupos. No entanto, o grupo termoablação 
por radiofrequência teve períodos de internação significativamente 
mais curtos (0,69±0,47) e ausência de atividades (8,62±4,53), 
com p<000,1. Conclusão: Pacientes submetidos à termoablação 
por radiofrequência apresentaram taxa de oclusão, recidiva clínica 
e melhora da qualidade de vida comparáveis à retirada completa 
da veia safena. No entanto, esses pacientes passaram menos 
tempo internados e ausentes de suas atividades diárias durante a 
recuperação.
Descritores: Ablação por cateter/métodos; Veia safena/cirurgia; Ondas 
de rádio; Qualidade de vida 
 ❚ INTRODUCTION
Chronic venous disease (CVD) affects approximately 
23% of population of the United States and 35% of 
Brazil, with a male: female ratio ranging from 1:2 to 
1:4.(1) Up to 6% of cases are in the advanced stage of 
disease, with trophic changes in the skin and open or 
healed ulcers, which substantially impacts the patients’ 
quality of life.(2,3)
Reflux in the great saphenous vein (GSV) is the most 
common cause for varicose veins and CVD.(4) However, 
this reflux may be segmental, especially in patients in 
the clinical category 2 (Comprehensive Classification 
System for Chronic Venous Disorders − CEAP), and is 
a reason for complaints regarding aesthetic aspects.(5,6)
The conventional techniques to treat chronic venous 
insufficiency (CVI) of the GSV and small saphenous 
vein (SSV) are the high ligation of the saphenofemoral 
junction (SFJ) or saphenopopliteal junction (SPJ), and 
the vein stripping. Recommendations to treat GSV 
are to strip the above-knee GSV due to saphenous 
nerve injury caused by complete GSV stripping.(2) 
However, in Brazil, the complete removal of the GSV 
is considered a standard treatment.(7) Theivacumar 
et al.,(8) showed greater satisfaction of patients, and 
Gifford et al.,(9) noted better long-term outcomes of 
patients undergoing complete stripping of the venous 
incompetence segment. Several authors recommend 
removing the entire GSV if a venous duplex evaluation 
confirms reflux to the ankle of over 1 second.(9-11) The 
SSV is usually removed from the SPJ to the mid-third 
of the leg, but it can be completely excised, especially in 
patients with severe disease.(12) This procedure usually 
requires hospitalization, has a high rate of recurrence 
and the patient may need at least 1 week to recover.(13)
Percutaneous techniques have significantly evolved, 
especially in the last decade, because they are safe, 
outpatient procedures. These techniques have medium-
term outcomes similar to the conventional treatment, 
but cause less pain and postoperative discomfort, 
allow an earlier return to work and have a lower rate 
of recurrence.(14,15) However, most studies compare 
ablative techniques to the stripping of the GSV limited to 
the knee, even though, in several countries, including 
Brazil, the standard technique to treat GSV reflux is high 
ligation and stripping of the SFJ to the ankle.(1,7,16-18)
The aim of this study was to compare the treatment 
of saphenous vein reflux using radiofrequency ablation 
(RFA) to treatment using ligation and complete 
stripping of the saphenous vein (S&T), in patients with 
CVD CEAP classes 2-4.
OBJECTIVE
To compare the use of the radiofrequency thermoablation 
of the saphenous vein with the technique of ligation 
and complete stripping of the saphenous vein, from the 
saphenopopliteal junction to the ankle.
 ❚ METHODS
Patients with CVD requiring treatment of the saphenous 
vein at Hospital Geral de Carapicuíba, of Organização 
Social de Saúde São Camilo, Carapicuíba (SP) Brazil, 
were recruited from February to September of 2013. 
All patients who met the inclusion criteria and were 
interested in volunteering were invited to participate 
in the study. The study was approved by the Research 
Ethics Committee of Hospital Geral de Carapicuíba 
(protocol number 021/12), and all procedures were 
performed in accordance with the Declaration of 
Helsinki and good practices in clinical research. All 
participants signed Informed Consent forms, and 
were free to leave the study at any moment, without 
interference in treatment. 
The patients were examined in the vascular 
outpatient clinic. A detailed history was taken and a 
complete physical examination was made. All patients 
had an Ankle-Brachial Index (ABI) measured and 
underwent color-Doppler venous ultrasound of the 
superficial and deep veins in the lower limbs. Age, sex, 
weight, comorbidities and body mass index (BMI) were 
recorded. The same physician determined the score 
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for each patient by using the revised Venous Clinical 
Severity Score (R-VCSS).(19-22) Furthermore, all patients 
filled in the Aberdeen Varicose Vein Questionnaire 
(AVVQ) for quality of life.(19-22)
Doppler venous ultrasound for reflux evaluation 
was performed by a vascular surgeon with experience in 
imaging examination of CVD patients, using a portable 
system (MySono 6 Samsung Medison Co., Seoul, Korea) 
with a 7 to 12MHz multi-frequency linear transducer. 
The examination was performed in the standing 
position with the body weight put on the contralateral 
limb. The deep venous system was evaluated for acute 
thrombophlebitis and post-thrombotic changes. The 
number and location of refluxing perforator veins were 
recorded. Reflux was induced by manual compression 
followed by sudden release. Retrograde flow lasting 
>0.5 second was used as cut-off for reflux in the 
saphenous vein. In this study, only patients with >1 
second reflux (diffused throughout the entire GSV) 
were included to avoid treating minimal disease. GSV 
diameters were measured 3cm away from the SFJ, 
at mid-thigh and at the knee. Small saphenous vein 
diameter was measured at the popliteal fossa, and at 
10cm below that level before beginning of treatment. 
The same measurements were taken 12 and 36 months 
after surgery. The ultrasound pattern of the treated 
saphenous vein flux was classified as with occlusion (or 
non-visualized); patent saphenous vein with reflux; and 
patent saphenous vein without reflux. 
The inclusion criteria were as follows: age between 
18 and 70 years; CEAP classes C2, C3 or C4 and 
presence of symptoms; ABI ≥0.9; GSV reflux of >1 
second (diffused throughout the entire GSV), with a 
minimum diameter of 5mm and maximum diameter of 
12mm; and SSV reflux of >1 second, with a minimum 
diameter of 3mm and maximum diameter of 12mm.
The exclusion criteria were patients unable to 
undergo Duplex ultrasound examination; presenting 
with acute thrombophlebitis or chronic obstruction of 
the saphenous vein detected in the duplex ultrasound 
exam; history of deep venous thrombosis; absence of 
clinical conditions for surgical treatment, even under 
local anesthesia; CEAP 0, 1.5 or 6; restricted mobility; 
pregnancy; peripheral arterial disease; saphenous vein 
diameter <5mm or >12mm; non-compliance with 
postoperative treatment protocol; and technical failure 
of the procedure.
Bilateral treatment was performed, and each limb 
received the same treatment. Both limbs were treated 
and in the same surgery. For the statistical analysis, 
each leg of the patients who underwent bilateral 
treatment was considered a distinct individual. Multiple 
treatments were allowed in the same procedure, such as 
thermoablation of GSV and anterior saphenous vein.
Randomization
Patients were randomized using the website 
sealedenvelope.com (https://www.sealedenvelope.com/). 
Two groups were generated: the first one received 
saphenous thermoablation (RFA Group) and the 
second group was treated with conventional stripping 
(S&T Group).
Analyzed outcomes
The outcomes were assessed at baseline, 4 weeks, 1 
year, and 3 years after treatment. Criteria for technical 
success were closed or absent saphenous vein with no 
flow. A recanalized saphenous vein or treatment failure 
were defined as an open part of the treated vein segment 
with more than 10cm in length; or a residual SFJ and 
SPJ with reflux. The primary outcome measured was 
recanalization rate for RFA Group, and saphenous 
vein neovascularization or surgical failure for the S&T 
Group, which were analyzed only at the 1- and 3-year 
follow-up. Secondary outcomes measured were length of 
hospital stay, period of absence from work or domestic 
activities, clinical recurrence rate, and R-VCSS and 
AVVQ, which were both analyzed at baseline (14 to 
30 days after the procedure), and in the 1-year follow-
up. AVVQ is a change-responsive tool, which has been 
internationally validated to assess quality of life in 
varicose vein patients.(19-22)
Furthermore, we evaluated demographic indices, 
comorbidities, BMI and adverse events associated to 
the methods used, such as infection, phlebitis, deep 
venous thrombosis, pulmonary embolism, or need for 
hospitalization.
Surgical procedure and operative technique
All patients from both groups were treated in the 
operating room. For the S&T Group, all procedures 
were performed under spinal block, through exposure 
of the SFJ in the groin, dissection and ligation of all 
tributaries, and ligation of the GSV next to the common 
femoral vein. Later, the GSV was dissected through a 
1-cm incision at the ankle level, and the phleboextractor 
was inserted in the cephalad direction. Saphenous 
stripping was performed from proximal to distal and 
hemostasis was obtained by compression for 10 minutes. 
The SSV was surgically treated through ligation of the 
SFJ and stripping of the segment with reflux up to the 
origin of the Achilles tendon. We avoided complete 
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stripping of the SSV due the risk of sural nerve injury.(17) 
The suture of incisions and phlebectomy healing 
were followed by extrinsic compression through a 
compressive tubular gauze bandage. Analgesics and 
non-steroid anti-inflammatory drugs were prescribed 
for 3 to 5 days.
The RFA Group was mostly treated under local 
anesthesia − only four patients, who did not agree to 
tumescent anesthesia, were given spinal blockage. With 
the patient in supine position, the GSV was punctured 
under echography, preferably in the middle third of the 
leg. A 7F-sheath was inserted, and the Closure FAST™ 
100 cm (Medtronic™, USA) catheter was placed 2 to 
3cm away from the terminal valve of the SFJ. Tumescent 
anesthesia was applied under ultrasound-guidance in the 
saphenous compartment and in the perivenous tissues. 
The tumescent solution was composed of 1,000mL of 
saline and 120mg of methylprednisolone. For those 
who chose for local anesthesia, the tumescent solution 
was composed of 1,000mL of saline, 40mL of lidocaine 
with epinephrine at 1%, 20mL of sodium bicarbonate at 
8.4%, and 120mg of methylprednisolone. On average, 
400mL of the solution were used in each limb, never 
exceeding the maximum dose of 7mg/kg of lidocaine. 
The patients were maintained in the Trendelenburg 
position for the ablation. Pressure over the treated 
area during ablation was made both by the ultrasound 
transducer and by hand. Small saphenous vein ablation 
was similar to that of the GSV. Varicose tributaries were 
treated during the same surgery using micro-incisions 
in both groups. Adjuvant procedures on varices and 
perforator vessels were limited to anesthesia sites. 
All patients were encouraged to use compression 
stockings and return to their routine physical activity as 
soon as possible.
Statistical analysis
Numerical variables were expressed as mean and 
standard deviation, or median and interquartile range, 
and minimum and maximum values. Categorical variables 
were described as absolute and relative frequencies. 
Both groups were compared in relation to demographic 
data, comorbidities and outcomes using Fisher’s exact 
test or χ2 test for categorical variables, and the Student’s 
t-test or Mann-Whitney’s test for numerical variables.
Models of generalized estimating equations were 
adjusted considering the relation between the two 
evaluations performed in the same patient, and the 
results were presented by estimated means and a 95% 
confidence interval. The models were adjusted by the 
Poisson distribution in the case of the R-VCSS, and by 
normal distribution for the quality of life score. For the 
CEAP classification, the adjustment was performed with 
multinomial distribution, and binomial distribution 
was used for the recanalization of treated saphenous 
vein in all patients analyzed.
The analyses were conducted using the IBM 
Statistical Package for the Social Sciences (SPSS) for 
Windows, version 19.0 (IBM Corp., Armonk, NY, 
USA), and significance level was set at 0.05.
RESULTS
A total of 186 patients were referred to primary 
outpatient care and, of those, 70 (37.6%) met the 
eligibility criteria and 53 (28.6%) consented to 
participate. Four patients were excluded after 
randomization. The final analysis included 49 patients 
with primary CVD of the saphenous vein. A total of 
26 patients were randomly assigned to the RFA Group 
and 23 to the S&T Group (Figure 1). After 4 weeks of 
treatment, all patients underwent clinical evaluation 
and duplex scan to identify any complications. There 
was no statistical difference in demographic data 
and clinical characteristics between the groups, as 
indicated in table 1.
The incidence of complications was similar between 
the groups (Table 2). They included thrombophlebitis 
in a thigh tributary and popliteal vein thrombosis in the 
RFA: radiofrequency ablation; S&T: complete stripping of the saphenous vein.
Figure 1. Assessment for eligibility, randomization, and outcomes
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Table 1. Comparison of epidemiological data between both groups 
Total (n=49)
Groups
RFA (n=26) S&T (n=23) p value
Sex, n (%)
Female 39 (79.6) 20 (76.9) 19 (82.6) 0.731*
Male 10 (20.4) 6 (23.1) 4 (17.4)
Age, years
Mean ± SD 46.6±11.9 44.1±11.7 49.3±11.7 0.128†
Minimum-maximum 21-70 21-68 23-70
BMI, kg/m2
Mean±SD 26.6±3.6 26.4±3.5 26.7±3.7 0.776†
Minimum-maximum 19.6-36.7 19.6-32.0 20.8-36.7
Unilateral involvement, n (%) 31 17 (65.4) 14 (60.9)
Saphenous-vein involvement, n  
Great saphenous vein 63 34 29 0.596†
Small saphenous vein 6 3 3 0.948†
CEAP classification, n (%) 0.268‡
C2, varicose veins >3mm 19 (38.8) 9 (34.6) 10 (43.5)
C3, edema 19 (38.8) 11 (42.3) 8 (34.8)
C4, skin or subcutaneous change 11 (22.4) 6 (23.1) 5 (21.7)
Comorbidities, n (%)
SAH 13 (26.5) 7 (26.9) 6 (26.1) 0.947§
DM 5 (10.2) 1 (3.8) 4 (17.4) 0.173*
Smoking 8 (16.3) 6 (23.1) 2 (8.7) 0.254*
OAC 4 (8.2) 2 (7.7) 2 (8.7) 1.000*
Recurrence of varicose veins within 3 years, n (%)
No 37 (88.1) 21 (91.3) 16 (84.2) 0.638*
Yes 5 (11.9) 2 (8.7) 3 (15.8)
* Fisher’s exact test; † two sample t-test; ‡ generalized estimating equations; § Pearson χ2. 
RFA: radiofrequency ablation; S&T: complete stripping of the saphenous vein; SD: standard deviation; BMI: body mass index; CEAP: Comprehensive Classification System for Chronic Venous Disorders; SAH: sistemic arterial hypertension; DM: diabetes 
mellitus; OAC: oral anticoagulants.





RFA (n=26) S&T (n=23)
Complications
No 45 (91.8) 24 (92.3) 21 (91.3) 1.000*
Yes 4 (8.2) 2 (7.7) 2 (8.7)
Length of hospital stay, days 0.69±0.47 1.48±1.67 0.001†
Absence from work, days 8.62±4.53 20.13±18.76 <0.001†
Results expressed as n (%) or mean±standard deviation. * Fisher’s exact test; † Mann-Whitney test. 
RFA: radiofrequency ablation; S&T: complete stripping of the saphenous vein.
RFA Group, while one patient developed cellulitis and 
another developed deep venous thrombosis in the S&T 
Group (Table 2).
Patients in the S&T Group reported a longer 
time of absence from work or from house activities 
(20.13±18.76) than those in the RFA Group (8.62±4.53). 
Length of hospital stay was also significantly longer for 
the S&T Group (1.48±1.67) than for the RFA Group 
(0.69±0.47). Moreover, the RFA Group stayed at the 
hospital for a maximum of 1 day, whereas hospitalization 
ranged from 1 to 9 days for patients in the S&T Group. 
In the S&T Group, one patient had a secondary 
infection (cellulitis) and required hospitalization for 
antibiotic therapy.
Both R-VCSS and AVVQ significantly improved 
(p<0.001) between pre- and postoperative evaluations 
for all patients (Table 3), but there was no difference 
in R-VCSS (p=0.636) or AVVQ scores (p=0.163) 
between the RFA and S&T Groups (Tables 3 and 4). 
Both procedures significantly improved CEAP 
classification (p<0.001) of all participants, but there 
was no difference (p=0.268) in CEAP classifications 
between the groups.
Twelve months after treatment, on average, 67 
limbs of 49 patients (35 from the RFA Group and 32 
from the S&T Group) were evaluated by ultrasound 
(Table 5). Overall technical failure rate was 5.2%, 
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In the next follow-up session (37.1 months, on 
average), in which 42 study participants returned for 
ultrasound and medical evaluation, a total of 58 limbs 
were analyzed (31 from the RFA Group and 27 from 
the S&T Group), resulting in the identification of one 
new technical failure (saphenous recanalization) in the 
RFA Group. Thus, the success rate per limb was 93.4% 
for the RFA Group and 88.8% to the S&T Group 
(p=0.540).
The clinical recurrence of varicose veins in 3 
years was not significantly different in the two groups 
(p=0.638), with only two cases in RFA Group (8.7%) 
and three cases in the S&T Group (15.8%).
 ❚ DISCUSSION
This study shows that RFA allows for a shorter period of 
hospitalization and absence from work when compared 
to the S&T Group, as previously demonstrated by 
Lurie et al.,(13) and other studies.(23,24) Furthermore, the 
data presented here confirm the good clinical results of 
RFA regarding venous occlusion rates and impact on 
quality of life of patients treated, during the medium-
term follow-up. We found a 93.4% occlusion rate per 
limb in the RFA group after 3 years, similar to the 
results described by Proebstle et al.,(25) who reported a 
95% reflux-free rate, 5 years after RFA. We identified 
two cases of saphenous vein recanalization after RFA: 
one partial recanalization at knee level, and one 
neovascularization of the saphenous vein trunk at mid-
thigh. However, one of the patients had no complaints 
about venous insufficiency, corroborating the recent 
publications that have demonstrated ablation of the 
saphenous vein improves VCSS, despite failing to close 
it completely.(26) Recently, the results of the original 
VNUS closure device to eliminate truncal venous reflux 
at 15 years were reported, demonstrating excellent 
long-term technical success in truncal veins with the 
first-generation device.(27)
In the S&T Group, we believe most recurrences 
are due to the current standard technique, with no 
intraoperative ultrasound assessment. Additionally, 
there was no permanent clinical nerve injury detected in 
any of the groups, even in those patients who underwent 
stripping from the SFJ to the ankle. Although we 
did not perform a specific protocol for nerve injury 
evaluation, our results are similar to those described by 
Morrison et al.(10) The authors suggest that saphenous 
nerve deficits after stripping of the GSV to the ankle 
have little clinical significance. In contrast, other 
reports found in the literature showed a risk of nerve 
injury after stripping below the knee as high as 39%.(17) 





Failure rate 1 year 5.2 (0.0-11.0) 2.9 (0.0-8.4) 9.4 (0.0-19.4) 0.266*
Limbs treated 67 35 32
Failure rate 3 year 8.6 (1.2-16.0) 6.6 (0.0-15.5) 11.2 (0.0-23.1) 0.540*
Limbs treated 58 31 27
Results expressed as 95% confidence interval and n. * Generalized estimating equations. 
RFA: radiofrequency ablation; S&T: complete stripping of the saphenous vein.
Table 4. Results of the Revised Venous Clinical Severity Score in patients 




RFA (n=26) S&T (n=23)
Evaluation
Preoperative 7.68 (6.81-8.55) 7.58 (6.37-8.79) 7.78 (6.52-9.04)
Postoperative 4.17 (3.49-4.85) 4.00 (2.91-5.09) 4.35 (3.56-5.13)
Tests of model effects*
Technique versus evaluation p=0.737
Technique p=0.636
Evaluation p<0.001
Difference (pre-post) 3.51 (2.60-4.42) 3.58 (2.22-4.94) 3.43 (2.24-4.63)
p<0.001 p<0.001 p<0.001
Results expressed as estimated means and 95% confidence intervals. * Generalized estimating equations. 
RFA: radiofrequency ablation; S&T: complete stripping of the saphenous vein.
Table 3. Results of Aberdeen Varicose Veins Questionnaire in study participants, 





RFA (n=26) S&T (n=23)
Evaluation
Preoperative 24.2 (20.7-27.6) 22.6 (18.7-26.6) 25.7 (20.1-31.3)
Postoperative 14.7 (12.7-16.6) 13.0 (10.4-15.7) 16.3 (13.5-19.2)
Tests of model effects*
Technique versus evaluation p=0.964
Technique p=0.163
Evaluation p<0.001
Difference (pre-post) 9.5 (6.1-12.8) 9.6 (5.5-13.6) 9.4 (4.1-14.8)
p<0.001 p<0.001 p<0.001
Results expressed as estimated means and 95% confidence intervals. * Generalized estimating equations. 
RFA: radiofrequency ablation; S&T: complete stripping of the saphenous vein.
with one recanalization in the RFA Group (2.9%) 
and three surgical failures in the S&T Group (9.4%). 
In the latter, there were two cases of reflux in residual 
segments of GSV, and one case of incomplete ligation 
of SSV, maintaining venous reflux to gastrocnemial and 
superficial varicose veins.
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Furthermore, clinical dynamics such as surgical time, 
perioperative and temporary post-operative care, and 
antibiotic therapy were similar between the RFA and 
S&T Groups.
In the first two decades of the this century, there 
were significant advances in techniques used to treat 
saphenous trunk reflux, especially in the ultrasound-
guided minimally invasive techniques.(28) There are 
numerous studies demonstrating encouraging results 
with these techniques.(24,29) The earlier return to daily 
activities and the decrease in postoperative pain, in 
comparison to the conventional technique, have been 
well established since the use of the first radiofrequency 
catheters.(13) After technological advances in the 
ablation device, radiofrequency started to present 
even better results.(30) This led the American Venous 
Forum guidelines to recommend endovenous 
thermoablation instead of the conventional technique.(2) 
Since then, several publications recommending the 
same treatment to vascular specialist have been 
published, especially in developed countries.(31) A 
recent survey with surgeons, who are members of 
the American Venous Forum (mostly US residents), 
identified that 47% of them favor radiofrequency 
ablation and 40% prefer laser ablation of the 
GSV.(32) However, this paradigm change in CVD 
treatment through endovenous thermoablation is 
not yet globally disseminated.
Our main objective was to compare the standard 
of care in Brazil (complete stripping) to the standard 
of care in developed countries (thermoablation).(2) We 
focused on the most prevalent group of CVD (CEAP 
classes 2, 3 and 4) for a better data analysis, and our 
results were corroborated by most data previously 
published.(22,25,33)
This is the first randomized Brazilian trial 
with mid-term follow-up (3 years) that compared 
the complete stripping of saphenous vein for CVD 
treatment with a minimally invasive technique. This study 
reproduced the good results reported in the literature 
in the last 20 years, opening a new perspective for 
the treatment of axial saphenous reflux in developing 
countries. Since this technology requires additional 
equipment and supplies, it is necessary to perform a 
detailed economic analysis of the financial impact of 
the endovenous technique on the public health system. 
Lower hospitalization rates and shorter work absence 
periods must be considered when assessing the cost of 
implementing the new techniques, since they may be 
beneficial to society.
 ❚ CONCLUSION
Patients submitted to radiofrequency thermoablation 
had an occlusion rate, clinical recurrence and improvement 
in quality of life that were comparable to those of patients 
who underwent complete stripping of the saphenous vein. 
However, the patients who underwent radiofrequency 
thermoablation showed an improvement in quality 
of life, spent significantly less time at the hospital and 
were absent from work for a shorter period of time in 
comparison to those who underwent the traditional 
technique. Further studies should evaluate the cost-
benefit ratio of these minimally invasive techniques.
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